GAITHERSBURG, Md., March 6,
2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a
global company advancing protein-based vaccines with its novel
Matrix-M™ adjuvant, today announced that it will participate in TD
Cowen's 43rd Annual Health Care Conference.
Conference
Details:
|
|
|
Fireside
Chat
|
|
Date:
|
Wednesday, March 8,
2023
|
Time:
|
9:50 – 10:20 a.m.
Eastern Standard Time (EST)
|
Location:
|
Boston Marriott Copley
Place in Boston, Massachusetts
|
Moderator:
|
Georgi Yordanov, Equity
Research Analyst – Biotechnology
|
Novavax
participant:
|
John Trizzino, Chief
Commercial Officer and Chief Business
Officer
|
|
|
|
Conference
|
|
Event:
|
Investor
Meetings
|
Date:
|
Wednesday, March 8,
2023
|
|
|
|
|
|
|
|
|
|
|
Recordings
A replay of the recorded fireside session
will be available through the Events & presentations page of
the Company's website at ir.novavax.com for 90 days from the
date of the conference.
About Novavax
Novavax, Inc. (Nasdaq: NVAX) promotes
improved health by discovering, developing and commercializing
innovative vaccines to protect against serious infectious diseases.
Novavax, a global company based in Gaithersburg, Md., U.S., offers a
differentiated vaccine platform that combines a recombinant protein
approach, innovative nanoparticle technology and Novavax's patented
Matrix-M adjuvant to enhance the immune response. Focused on the
world's most urgent health challenges, Novavax is currently
evaluating vaccines for COVID-19, influenza, and COVID-19 and
influenza combined. Please visit novavax.com and LinkedIn for more
information.
CONTACTS
Investors
Erika Schultz
240-268-2022
ir@novavax.com
Media
Ali Chartan
240-720-7804
media@novavax.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-td-cowens-43rd-annual-health-care-conference-301762705.html
SOURCE Novavax, Inc.